img

Global GP Vaccination Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global GP Vaccination Market Research Report 2024

According to Mr Accuracy reports new survey, global GP Vaccination market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole GP Vaccination market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global GP Vaccination market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Takis Biotech
Zydus Cadila
Codagenix
GeoVax
Bravovax
Altimmune
Vaxart
Clover Biopharmaceuticals
ImmunoPrecise
Segment by Type
DNA
Non-replicating Viral Vector
Protein Subunit
RNA
Others

Segment by Application


Adults
Children

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The GP Vaccination report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 GP Vaccination Market Overview
1.1 Product Overview and Scope of GP Vaccination
1.2 GP Vaccination Segment by Type
1.2.1 Global GP Vaccination Market Value Comparison by Type (2024-2034)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
1.3 GP Vaccination Segment by Application
1.3.1 Global GP Vaccination Market Value by Application: (2024-2034)
1.3.2 Adults
1.3.3 Children
1.4 Global GP Vaccination Market Size Estimates and Forecasts
1.4.1 Global GP Vaccination Revenue 2018-2029
1.4.2 Global GP Vaccination Sales 2018-2029
1.4.3 Global GP Vaccination Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 GP Vaccination Market Competition by Manufacturers
2.1 Global GP Vaccination Sales Market Share by Manufacturers (2018-2024)
2.2 Global GP Vaccination Revenue Market Share by Manufacturers (2018-2024)
2.3 Global GP Vaccination Average Price by Manufacturers (2018-2024)
2.4 Global GP Vaccination Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of GP Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GP Vaccination, Product Type & Application
2.7 GP Vaccination Market Competitive Situation and Trends
2.7.1 GP Vaccination Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest GP Vaccination Players Market Share by Revenue
2.7.3 Global GP Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 GP Vaccination Retrospective Market Scenario by Region
3.1 Global GP Vaccination Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global GP Vaccination Global GP Vaccination Sales by Region: 2018-2029
3.2.1 Global GP Vaccination Sales by Region: 2018-2024
3.2.2 Global GP Vaccination Sales by Region: 2024-2029
3.3 Global GP Vaccination Global GP Vaccination Revenue by Region: 2018-2029
3.3.1 Global GP Vaccination Revenue by Region: 2018-2024
3.3.2 Global GP Vaccination Revenue by Region: 2024-2029
3.4 North America GP Vaccination Market Facts & Figures by Country
3.4.1 North America GP Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America GP Vaccination Sales by Country (2018-2029)
3.4.3 North America GP Vaccination Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe GP Vaccination Market Facts & Figures by Country
3.5.1 Europe GP Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe GP Vaccination Sales by Country (2018-2029)
3.5.3 Europe GP Vaccination Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GP Vaccination Market Facts & Figures by Country
3.6.1 Asia Pacific GP Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific GP Vaccination Sales by Country (2018-2029)
3.6.3 Asia Pacific GP Vaccination Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GP Vaccination Market Facts & Figures by Country
3.7.1 Latin America GP Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America GP Vaccination Sales by Country (2018-2029)
3.7.3 Latin America GP Vaccination Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa GP Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa GP Vaccination Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa GP Vaccination Sales by Country (2018-2029)
3.8.3 Middle East and Africa GP Vaccination Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GP Vaccination Sales by Type (2018-2029)
4.1.1 Global GP Vaccination Sales by Type (2018-2024)
4.1.2 Global GP Vaccination Sales by Type (2024-2029)
4.1.3 Global GP Vaccination Sales Market Share by Type (2018-2029)
4.2 Global GP Vaccination Revenue by Type (2018-2029)
4.2.1 Global GP Vaccination Revenue by Type (2018-2024)
4.2.2 Global GP Vaccination Revenue by Type (2024-2029)
4.2.3 Global GP Vaccination Revenue Market Share by Type (2018-2029)
4.3 Global GP Vaccination Price by Type (2018-2029)
5 Segment by Application
5.1 Global GP Vaccination Sales by Application (2018-2029)
5.1.1 Global GP Vaccination Sales by Application (2018-2024)
5.1.2 Global GP Vaccination Sales by Application (2024-2029)
5.1.3 Global GP Vaccination Sales Market Share by Application (2018-2029)
5.2 Global GP Vaccination Revenue by Application (2018-2029)
5.2.1 Global GP Vaccination Revenue by Application (2018-2024)
5.2.2 Global GP Vaccination Revenue by Application (2024-2029)
5.2.3 Global GP Vaccination Revenue Market Share by Application (2018-2029)
5.3 Global GP Vaccination Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Corporation Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Moderna GP Vaccination Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 CanSino Biologicals
6.2.1 CanSino Biologicals Corporation Information
6.2.2 CanSino Biologicals Description and Business Overview
6.2.3 CanSino Biologicals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.2.4 CanSino Biologicals GP Vaccination Product Portfolio
6.2.5 CanSino Biologicals Recent Developments/Updates
6.3 Inovio Pharmaceuticals
6.3.1 Inovio Pharmaceuticals Corporation Information
6.3.2 Inovio Pharmaceuticals Description and Business Overview
6.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Inovio Pharmaceuticals GP Vaccination Product Portfolio
6.3.5 Inovio Pharmaceuticals Recent Developments/Updates
6.4 Shenzhen Geno-Immune Medical Institute
6.4.1 Shenzhen Geno-Immune Medical Institute Corporation Information
6.4.2 Shenzhen Geno-Immune Medical Institute Description and Business Overview
6.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Portfolio
6.4.5 Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
6.5 GlaxoSmithKine
6.5.1 GlaxoSmithKine Corporation Information
6.5.2 GlaxoSmithKine Description and Business Overview
6.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.5.4 GlaxoSmithKine GP Vaccination Product Portfolio
6.5.5 GlaxoSmithKine Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Pfizer GP Vaccination Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Johnson＆Johnson
6.6.1 Johnson＆Johnson Corporation Information
6.6.2 Johnson＆Johnson Description and Business Overview
6.6.3 Johnson＆Johnson GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Johnson＆Johnson GP Vaccination Product Portfolio
6.7.5 Johnson＆Johnson Recent Developments/Updates
6.8 Heat Biologics
6.8.1 Heat Biologics Corporation Information
6.8.2 Heat Biologics Description and Business Overview
6.8.3 Heat Biologics GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Heat Biologics GP Vaccination Product Portfolio
6.8.5 Heat Biologics Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Corporation Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Sanofi GP Vaccination Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Takis Biotech
6.10.1 Takis Biotech Corporation Information
6.10.2 Takis Biotech Description and Business Overview
6.10.3 Takis Biotech GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Takis Biotech GP Vaccination Product Portfolio
6.10.5 Takis Biotech Recent Developments/Updates
6.11 Zydus Cadila
6.11.1 Zydus Cadila Corporation Information
6.11.2 Zydus Cadila GP Vaccination Description and Business Overview
6.11.3 Zydus Cadila GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zydus Cadila GP Vaccination Product Portfolio
6.11.5 Zydus Cadila Recent Developments/Updates
6.12 Codagenix
6.12.1 Codagenix Corporation Information
6.12.2 Codagenix GP Vaccination Description and Business Overview
6.12.3 Codagenix GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Codagenix GP Vaccination Product Portfolio
6.12.5 Codagenix Recent Developments/Updates
6.13 GeoVax
6.13.1 GeoVax Corporation Information
6.13.2 GeoVax GP Vaccination Description and Business Overview
6.13.3 GeoVax GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.13.4 GeoVax GP Vaccination Product Portfolio
6.13.5 GeoVax Recent Developments/Updates
6.14 Bravovax
6.14.1 Bravovax Corporation Information
6.14.2 Bravovax GP Vaccination Description and Business Overview
6.14.3 Bravovax GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Bravovax GP Vaccination Product Portfolio
6.14.5 Bravovax Recent Developments/Updates
6.15 Altimmune
6.15.1 Altimmune Corporation Information
6.15.2 Altimmune GP Vaccination Description and Business Overview
6.15.3 Altimmune GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Altimmune GP Vaccination Product Portfolio
6.15.5 Altimmune Recent Developments/Updates
6.16 Vaxart
6.16.1 Vaxart Corporation Information
6.16.2 Vaxart GP Vaccination Description and Business Overview
6.16.3 Vaxart GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Vaxart GP Vaccination Product Portfolio
6.16.5 Vaxart Recent Developments/Updates
6.17 Clover Biopharmaceuticals
6.17.1 Clover Biopharmaceuticals Corporation Information
6.17.2 Clover Biopharmaceuticals GP Vaccination Description and Business Overview
6.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Clover Biopharmaceuticals GP Vaccination Product Portfolio
6.17.5 Clover Biopharmaceuticals Recent Developments/Updates
6.18 ImmunoPrecise
6.18.1 ImmunoPrecise Corporation Information
6.18.2 ImmunoPrecise GP Vaccination Description and Business Overview
6.18.3 ImmunoPrecise GP Vaccination Sales, Revenue and Gross Margin (2018-2024)
6.18.4 ImmunoPrecise GP Vaccination Product Portfolio
6.18.5 ImmunoPrecise Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GP Vaccination Industry Chain Analysis
7.2 GP Vaccination Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GP Vaccination Production Mode & Process
7.4 GP Vaccination Sales and Marketing
7.4.1 GP Vaccination Sales Channels
7.4.2 GP Vaccination Distributors
7.5 GP Vaccination Customers
8 GP Vaccination Market Dynamics
8.1 GP Vaccination Industry Trends
8.2 GP Vaccination Market Drivers
8.3 GP Vaccination Market Challenges
8.4 GP Vaccination Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global GP Vaccination Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global GP Vaccination Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global GP Vaccination Market Competitive Situation by Manufacturers in 2022
Table 4. Global GP Vaccination Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global GP Vaccination Sales Market Share by Manufacturers (2018-2024)
Table 6. Global GP Vaccination Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global GP Vaccination Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market GP Vaccination Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of GP Vaccination, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of GP Vaccination, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of GP Vaccination, Product Type & Application
Table 12. Global Key Manufacturers of GP Vaccination, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GP Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GP Vaccination as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GP Vaccination Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 18. Global GP Vaccination Sales Market Share by Region (2018-2024)
Table 19. Global GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 20. Global GP Vaccination Sales Market Share by Region (2024-2029)
Table 21. Global GP Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global GP Vaccination Revenue Market Share by Region (2018-2024)
Table 23. Global GP Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global GP Vaccination Revenue Market Share by Region (2024-2029)
Table 25. North America GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 27. North America GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 28. North America GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 32. Europe GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 33. Europe GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific GP Vaccination Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific GP Vaccination Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific GP Vaccination Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific GP Vaccination Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific GP Vaccination Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 42. Latin America GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 43. Latin America GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa GP Vaccination Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa GP Vaccination Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa GP Vaccination Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa GP Vaccination Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa GP Vaccination Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global GP Vaccination Sales (K Units) by Type (2018-2024)
Table 51. Global GP Vaccination Sales (K Units) by Type (2024-2029)
Table 52. Global GP Vaccination Sales Market Share by Type (2018-2024)
Table 53. Global GP Vaccination Sales Market Share by Type (2024-2029)
Table 54. Global GP Vaccination Revenue (US$ Million) by Type (2018-2024)
Table 55. Global GP Vaccination Revenue (US$ Million) by Type (2024-2029)
Table 56. Global GP Vaccination Revenue Market Share by Type (2018-2024)
Table 57. Global GP Vaccination Revenue Market Share by Type (2024-2029)
Table 58. Global GP Vaccination Price (US$/Unit) by Type (2018-2024)
Table 59. Global GP Vaccination Price (US$/Unit) by Type (2024-2029)
Table 60. Global GP Vaccination Sales (K Units) by Application (2018-2024)
Table 61. Global GP Vaccination Sales (K Units) by Application (2024-2029)
Table 62. Global GP Vaccination Sales Market Share by Application (2018-2024)
Table 63. Global GP Vaccination Sales Market Share by Application (2024-2029)
Table 64. Global GP Vaccination Revenue (US$ Million) by Application (2018-2024)
Table 65. Global GP Vaccination Revenue (US$ Million) by Application (2024-2029)
Table 66. Global GP Vaccination Revenue Market Share by Application (2018-2024)
Table 67. Global GP Vaccination Revenue Market Share by Application (2024-2029)
Table 68. Global GP Vaccination Price (US$/Unit) by Application (2018-2024)
Table 69. Global GP Vaccination Price (US$/Unit) by Application (2024-2029)
Table 70. Moderna Corporation Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Moderna GP Vaccination Product
Table 74. Moderna Recent Developments/Updates
Table 75. CanSino Biologicals Corporation Information
Table 76. CanSino Biologicals Description and Business Overview
Table 77. CanSino Biologicals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. CanSino Biologicals GP Vaccination Product
Table 79. CanSino Biologicals Recent Developments/Updates
Table 80. Inovio Pharmaceuticals Corporation Information
Table 81. Inovio Pharmaceuticals Description and Business Overview
Table 82. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Inovio Pharmaceuticals GP Vaccination Product
Table 84. Inovio Pharmaceuticals Recent Developments/Updates
Table 85. Shenzhen Geno-Immune Medical Institute Corporation Information
Table 86. Shenzhen Geno-Immune Medical Institute Description and Business Overview
Table 87. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Shenzhen Geno-Immune Medical Institute GP Vaccination Product
Table 89. Shenzhen Geno-Immune Medical Institute Recent Developments/Updates
Table 90. GlaxoSmithKine Corporation Information
Table 91. GlaxoSmithKine Description and Business Overview
Table 92. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. GlaxoSmithKine GP Vaccination Product
Table 94. GlaxoSmithKine Recent Developments/Updates
Table 95. Pfizer Corporation Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Pfizer GP Vaccination Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Johnson＆Johnson Corporation Information
Table 101. Johnson＆Johnson Description and Business Overview
Table 102. Johnson＆Johnson GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Johnson＆Johnson GP Vaccination Product
Table 104. Johnson＆Johnson Recent Developments/Updates
Table 105. Heat Biologics Corporation Information
Table 106. Heat Biologics Description and Business Overview
Table 107. Heat Biologics GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Heat Biologics GP Vaccination Product
Table 109. Heat Biologics Recent Developments/Updates
Table 110. Sanofi Corporation Information
Table 111. Sanofi Description and Business Overview
Table 112. Sanofi GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Sanofi GP Vaccination Product
Table 114. Sanofi Recent Developments/Updates
Table 115. Takis Biotech Corporation Information
Table 116. Takis Biotech Description and Business Overview
Table 117. Takis Biotech GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Takis Biotech GP Vaccination Product
Table 119. Takis Biotech Recent Developments/Updates
Table 120. Zydus Cadila Corporation Information
Table 121. Zydus Cadila Description and Business Overview
Table 122. Zydus Cadila GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Zydus Cadila GP Vaccination Product
Table 124. Zydus Cadila Recent Developments/Updates
Table 125. Codagenix Corporation Information
Table 126. Codagenix Description and Business Overview
Table 127. Codagenix GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Codagenix GP Vaccination Product
Table 129. Codagenix Recent Developments/Updates
Table 130. GeoVax Corporation Information
Table 131. GeoVax Description and Business Overview
Table 132. GeoVax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. GeoVax GP Vaccination Product
Table 134. GeoVax Recent Developments/Updates
Table 135. Bravovax Corporation Information
Table 136. Bravovax Description and Business Overview
Table 137. Bravovax GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Bravovax GP Vaccination Product
Table 139. Bravovax Recent Developments/Updates
Table 140. Altimmune Corporation Information
Table 141. Altimmune Description and Business Overview
Table 142. Altimmune GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Altimmune GP Vaccination Product
Table 144. Altimmune Recent Developments/Updates
Table 145. Vaxart Corporation Information
Table 146. Vaxart Description and Business Overview
Table 147. Vaxart GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Vaxart GP Vaccination Product
Table 149. Vaxart Recent Developments/Updates
Table 150. Clover Biopharmaceuticals Corporation Information
Table 151. Clover Biopharmaceuticals Description and Business Overview
Table 152. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Clover Biopharmaceuticals GP Vaccination Product
Table 154. Clover Biopharmaceuticals Recent Developments/Updates
Table 155. ImmunoPrecise Corporation Information
Table 156. ImmunoPrecise Description and Business Overview
Table 157. ImmunoPrecise GP Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. ImmunoPrecise GP Vaccination Product
Table 159. ImmunoPrecise Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. GP Vaccination Distributors List
Table 163. GP Vaccination Customers List
Table 164. GP Vaccination Market Trends
Table 165. GP Vaccination Market Drivers
Table 166. GP Vaccination Market Challenges
Table 167. GP Vaccination Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of GP Vaccination
Figure 2. Global GP Vaccination Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global GP Vaccination Market Share by Type in 2022 & 2029
Figure 4. DNA Product Picture
Figure 5. Non-replicating Viral Vector Product Picture
Figure 6. Protein Subunit Product Picture
Figure 7. RNA Product Picture
Figure 8. Others Product Picture
Figure 9. Global GP Vaccination Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global GP Vaccination Market Share by Application in 2022 & 2029
Figure 11. Adults
Figure 12. Children
Figure 13. Global GP Vaccination Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global GP Vaccination Market Size (2018-2029) & (US$ Million)
Figure 15. Global GP Vaccination Sales (2018-2029) & (K Units)
Figure 16. Global GP Vaccination Average Price (US$/Unit) & (2018-2029)
Figure 17. GP Vaccination Report Years Considered
Figure 18. GP Vaccination Sales Share by Manufacturers in 2022
Figure 19. Global GP Vaccination Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest GP Vaccination Players: Market Share by Revenue in 2022
Figure 21. GP Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global GP Vaccination Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America GP Vaccination Sales Market Share by Country (2018-2029)
Figure 24. North America GP Vaccination Revenue Market Share by Country (2018-2029)
Figure 25. U.S. GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe GP Vaccination Sales Market Share by Country (2018-2029)
Figure 28. Europe GP Vaccination Revenue Market Share by Country (2018-2029)
Figure 29. Germany GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific GP Vaccination Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific GP Vaccination Revenue Market Share by Region (2018-2029)
Figure 36. China GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. China Taiwan GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Southeast Asia GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America GP Vaccination Sales Market Share by Country (2018-2029)
Figure 44. Latin America GP Vaccination Revenue Market Share by Country (2018-2029)
Figure 45. Mexico GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa GP Vaccination Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa GP Vaccination Revenue Market Share by Country (2018-2029)
Figure 50. Turkey GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE GP Vaccination Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of GP Vaccination by Type (2018-2029)
Figure 54. Global Revenue Market Share of GP Vaccination by Type (2018-2029)
Figure 55. Global GP Vaccination Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of GP Vaccination by Application (2018-2029)
Figure 57. Global Revenue Market Share of GP Vaccination by Application (2018-2029)
Figure 58. Global GP Vaccination Price (US$/Unit) by Application (2018-2029)
Figure 59. GP Vaccination Value Chain
Figure 60. GP Vaccination Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries